Lycopene improves on basic hematological and immunological parameters in diabetes mellitus

dc.contributor.authorEjike, Daniel Eze
dc.contributor.authorAdam, Moyosore Afodun
dc.contributor.authorJosephine, Kasolo
dc.contributor.authorKeneth Iceland, Kasozi
dc.date.accessioned2023-02-22T06:52:43Z
dc.date.available2023-02-22T06:52:43Z
dc.date.issued2019
dc.description.abstractObjective: Diabetes is associated with an upset of hematological and immunological parameters in humans, how- ever information on the effects of Lycopene is scarce. The aim of the study was to gain information on basic changes in hematological parameters as markers for safety since anemia as a complication in diabetic chemotherapy has been reported. Results: Lycopene had anti-anemic effects and improved on the immune status of diabetic rats and these obser- vations were dose independent. There was a decrease in neutrophil, low neutrophil–lymphocyte ratio and platelet counts and stable albumin, globulin levels. Lycopene could exert its protective effects through a balance of basic hematological physiological variables.en_US
dc.description.sponsorshipKabale Universityen_US
dc.identifier.urihttp://hdl.handle.net/20.500.12493/1016
dc.language.isoenen_US
dc.publisherBMC Research Notesen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectAntioxidantsen_US
dc.subjectDiabetesen_US
dc.subjectAnemiaen_US
dc.subjectCarotenoidsen_US
dc.subjectBlooden_US
dc.titleLycopene improves on basic hematological and immunological parameters in diabetes mellitusen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2 BMC PUBLISHED ARTICLE s13104-019-4841-8.pdf
Size:
1.87 MB
Format:
Adobe Portable Document Format
Description:
Lycopene improves on basic hematological and immunological parameters in diabetes mellitus
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: